Table 3.
Multivariate linear regression analysis of the serum spike-specific IgG levels of SARS-CoV-2 vaccinated subjects compared to COVID-19 convalescent subjects.
| Vaccinated HU | Vaccinated HIV | |||
|---|---|---|---|---|
| Variable | Estimates (95% CI) | p Value | Estimates (95% CI) | p Value |
| (Intercept) | 8.29 (7.76 to 8.82) | <0.0001 | 7.89 (7.35 to 8.42) | <0.0001 |
| Age, per decade | −0.14 (−0.36 to 0.09) | 0.242 | −0.14 (−0.36 to 0.09) | 0.242 |
| COVID HU | −3.44 (−4.41 to −2.48) | <0.0001 | −3.04 (−4.03 to −2.05) | <0.0001 |
| COVID HIV | −3.38 (−4.24 to −2.52) | <0.0001 | −2.98 (−3.86 to −2.09) | <0.0001 |
| Female gender | 0.37 (−0.21 to 0.96) | 0.208 | 0.37 (−0.21 to 0.96) | 0.208 |
| Time after vaccine, per week | −0.12 (−0.16 to −0.07) | <0.0001 | −0.12 (−0.16 to −0.07) | <0.0001 |